ZBTB49

gene
On this page

Also known as FLJ38559

Summary

ZBTB49 (zinc finger and BTB domain containing 49, HGNC:19883) is a protein-coding gene on chromosome 4p16.3, encoding Zinc finger and BTB domain-containing protein 49 (Q6ZSB9). Transcription factor.

Enables DNA-binding transcription factor binding activity; sequence-specific DNA binding activity; and transcription coactivator binding activity. Involved in negative regulation of cell population proliferation; positive regulation of transcription by RNA polymerase II; and regulation of cell cycle. Located in cytosol; microtubule cytoskeleton; and nucleoplasm.

Source: NCBI Gene 166793 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 115 total
  • MANE Select transcript: NM_145291

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19883
Approved symbolZBTB49
Namezinc finger and BTB domain containing 49
Location4p16.3
Locus typegene with protein product
StatusApproved
AliasesFLJ38559
Ensembl geneENSG00000168826
Ensembl biotypeprotein_coding
OMIM616238
Entrez166793

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 7 protein_coding, 3 nonsense_mediated_decay

ENST00000337872, ENST00000502918, ENST00000503703, ENST00000504302, ENST00000511458, ENST00000515012, ENST00000880133, ENST00000880134, ENST00000924925, ENST00000942737

RefSeq mRNA: 2 — MANE Select: NM_145291 NM_001330625, NM_145291

CCDS: CCDS3375

Canonical transcript exons

ENST00000337872 — 8 exons

ExonStartEnd
ENSE0000116195643061384306184
ENSE0000181627142902514290352
ENSE0000347313543019894303091
ENSE0000352655943130414313114
ENSE0000352965743206404321783
ENSE0000355602343158094315970
ENSE0000355827643156364315718
ENSE0000363012542999274300097

Expression profiles

Bgee: expression breadth ubiquitous, 187 present calls, max score 94.91.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8863 / max 74.3740, expressed in 1669 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
467314.88631669

Top tissues by expression

231 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002394.91gold quality
secondary oocyteCL:000065593.61gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.10gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.31gold quality
ventricular zoneUBERON:000305380.28gold quality
granulocyteCL:000009480.09gold quality
tibialis anteriorUBERON:000138578.77silver quality
cortical plateUBERON:000534378.67gold quality
pituitary glandUBERON:000000777.76gold quality
ganglionic eminenceUBERON:000402376.96gold quality
adenohypophysisUBERON:000219676.66gold quality
gastrocnemiusUBERON:000138875.82gold quality
muscle of legUBERON:000138375.53gold quality
right ovaryUBERON:000211875.21gold quality
bloodUBERON:000017874.96gold quality
popliteal arteryUBERON:000225074.77gold quality
tibial arteryUBERON:000761074.77gold quality
leukocyteCL:000073874.73gold quality
monocyteCL:000057674.42gold quality
tendon of biceps brachiiUBERON:000818874.25gold quality
smooth muscle tissueUBERON:000113574.20gold quality
calcaneal tendonUBERON:000370174.09gold quality
tendonUBERON:000004374.00gold quality
stromal cell of endometriumCL:000225573.93gold quality
spleenUBERON:000210673.83gold quality
left ovaryUBERON:000211973.69gold quality
vermiform appendixUBERON:000115473.58gold quality
aortaUBERON:000094773.44gold quality
ectocervixUBERON:001224973.43gold quality
muscle layer of sigmoid colonUBERON:003580573.13gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-100618yes151.05
E-MTAB-6379no173.15
E-ANND-3no2.22

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting ZBTB49, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-5692A100.0074.406850
HSA-MIR-548AW99.9972.573559
HSA-MIR-569699.9872.364487
HSA-MIR-369-3P99.8570.522264
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-187-5P99.7470.261404
HSA-MIR-808499.7369.571760
HSA-MIR-472999.6972.184233
HSA-MIR-3191-5P99.2466.521722
HSA-MIR-205499.2068.891699
HSA-MIR-6807-5P97.5164.251046
HSA-MIR-479496.4765.531063
HSA-MIR-6760-3P96.3568.311001
HSA-MIR-664A-5P95.8464.93949

Literature-anchored findings (GeneRIF, showing 2)

  • Two major ZNF509 isoforms are induced by p53 and act as downstream executioners of cell-cycle arrest by inducing expression of p21 and RB. (PMID:25245946)
  • ZNF509S1 modulation of p53 activity. (PMID:28757384)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriozbtb49ENSDARG00000102111
mus_musculusZbtb49ENSMUSG00000029127
rattus_norvegicusZbtb49ENSRNOG00000005633

Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)

Protein

Protein identifiers

Zinc finger and BTB domain-containing protein 49Q6ZSB9 (reviewed: Q6ZSB9)

Alternative names: Zinc finger protein 509

All UniProt accessions (6): Q6ZSB9, D6RB16, D6RC96, D6RJ00, H0Y8P2, H0YAD4

UniProt curated annotations — full annotation on UniProt →

Function. Transcription factor. Inhibits cell proliferation by activating either CDKN1A/p21 transcription or RB1 transcription. Binds CDKN1A promoter and activates its transcription; this activity is further potentiated in the presence of EP300 (synergistic) and ZBTB17/Miz-1 (additive). Activates RB1 transcription most probably by antagonizing ZBTB17 repression of RB1. Does not bind directly RB1 promoter.

Subunit / interactions. Isoform 1 interacts with EP300 and KAT5/Tip60. The interaction with EP300 is direct and leads to synergistic induction of CDKN1A. On the CDKN1A promoter, forms a complex with ZBTB17/Miz-1; this interaction leads to additive CDKN1A transactivation. Isoform 3 also interacts with ZBTB17; this interaction may block ZBTB17 repressor activity.

Subcellular location. Cytoplasm. Nucleus Cytoplasm. Nucleus.

Tissue specificity. Highly expressed in normal epidermis and in other epithelial tissues, including in colon and lung. Tends to be down-regulated in colon, lung and skin cancer tissues.

Induction. Induced by the DNA-damaging agent etoposide. This induction is mediated by TP53 at the transcriptional level.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (5)

UniProt IDNamesCanonical?
Q6ZSB9-11, ZNF509Lyes
Q6ZSB9-22
Q6ZSB9-33, ZNF509S1
Q6ZSB9-44, ZNF509S2
Q6ZSB9-55, ZNF509S3

RefSeq proteins (2): NP_001317554, NP_660334* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050457ZnFinger_BTB_dom_containFamily

Pfam: PF00096, PF00651, PF13912

UniProt features (24 total): zinc finger region 7, splice variant 6, sequence variant 4, sequence conflict 3, region of interest 2, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZSB9-F157.700.01

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 53 (showing top): CMYB_01, USF_C, MYCMAX_01, GOBP_CYTOKINE_PRODUCTION, GOBP_REGULATION_OF_CELL_CYCLE, chr4p16, GOMF_TRANSCRIPTION_COREGULATOR_BINDING, GOMF_TRANSCRIPTION_COACTIVATOR_BINDING, GOMF_TRANSCRIPTION_FACTOR_BINDING, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING

GO Biological Process (8): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682), negative regulation of cell population proliferation (GO:0008285), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of cell cycle (GO:0051726), pyrimidine nucleotide biosynthetic process (GO:0006221), positive regulation of DNA-templated transcription (GO:0045893)

GO Molecular Function (9): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), transcription coactivator binding (GO:0001223), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA-binding transcription factor binding (GO:0140297), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829), microtubule cytoskeleton (GO:0015630)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
regulation of transcription by RNA polymerase II2
transcription by RNA polymerase II2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
negative regulation of DNA-templated transcription1
cytokine production1
regulation of gene expression1
regulation of multicellular organismal process1
immune system process1
regulation of biological process1
cell population proliferation1
regulation of cell population proliferation1
negative regulation of cellular process1
positive regulation of DNA-templated transcription1
cell cycle1
regulation of cellular process1
pyrimidine nucleotide metabolic process1
nucleotide biosynthetic process1
pyrimidine-containing compound biosynthetic process1
DNA-templated transcription1
regulation of DNA-templated transcription1
positive regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
transcription coregulator binding1
negative regulation of transcription by RNA polymerase II1
DNA-binding transcription factor activity, RNA polymerase II-specific1
DNA-binding transcription repressor activity1
transition metal ion binding1
DNA binding1
transcription factor binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular anatomical structure1
cytoplasm1
cytoskeleton1

Protein interactions and networks

STRING

440 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZBTB49TMEM128Q5BJH2573
ZBTB49MSCO60682456
ZBTB49LYARQ9NX58438
ZBTB49STX18Q9P2W9406
ZBTB49OTOP1Q7RTM1358
ZBTB49NSG1P42857349
ZBTB49THAP1Q9NVV9338
ZBTB49ZNF862O60290327
ZBTB49RALGAPA2Q2PPJ7306
ZBTB49STK32BQ9NY57302
ZBTB49MEAF6Q9HAF1283
ZBTB49STRADBQ9C0K7279
ZBTB49CHORDC1Q9UHD1277
ZBTB49ZBTB41Q5SVQ8276
ZBTB49EVCP57679271
ZBTB49TAC4Q86UU9271

IntAct

57 interactions, top by confidence:

ABTypeScore
CEP70ZBTB49psi-mi:“MI:0915”(physical association)0.740
ZBTB49GOPCpsi-mi:“MI:0915”(physical association)0.740
ZBTB49CEP70psi-mi:“MI:0915”(physical association)0.740
GOPCZBTB49psi-mi:“MI:0915”(physical association)0.740
FBXL17BACH1psi-mi:“MI:0914”(association)0.730
ZBTB49ZBTB8Apsi-mi:“MI:0915”(physical association)0.720
ZBTB8AZBTB49psi-mi:“MI:0915”(physical association)0.720
ZBTB49GOPCpsi-mi:“MI:0915”(physical association)0.560
VAC14ZBTB49psi-mi:“MI:0915”(physical association)0.560
TRAF3ZBTB49psi-mi:“MI:0915”(physical association)0.560
ZBTB49PICK1psi-mi:“MI:0915”(physical association)0.560
ZBTB49ZBTB2psi-mi:“MI:0915”(physical association)0.560
TRAF2ZBTB49psi-mi:“MI:0915”(physical association)0.560
ZBTB49CIB1psi-mi:“MI:0915”(physical association)0.560
ZBTB49ATP1A3psi-mi:“MI:0915”(physical association)0.560
ZBTB49PECAM1psi-mi:“MI:0915”(physical association)0.560
VHLZBTB49psi-mi:“MI:0915”(physical association)0.560

BioGRID (42): ZBTB49 (Two-hybrid), ZBTB49 (Two-hybrid), ZBTB49 (Two-hybrid), ZBTB8A (Two-hybrid), KAT5 (Affinity Capture-Western), EP300 (Affinity Capture-Western), EP300 (Reconstituted Complex), ZBTB49 (Reconstituted Complex), ZBTB17 (FRET), ZBTB17 (Co-localization), ZBTB17 (Affinity Capture-Western), ZBTB49 (Affinity Capture-Western), HINFP (Affinity Capture-Western), ZBTB49 (Affinity Capture-Western), HINFP (Co-localization)

ESM2 similar proteins: A0A1D5NS60, A0JN76, A1YFX5, A2T7G6, A6NJL1, D2HQI1, F1MJR8, O14901, P0CG00, P10754, P22227, P98182, Q0IJ29, Q1L8W0, Q3SWU4, Q5DW34, Q5EAC5, Q5EXX3, Q5RHB5, Q5SXI5, Q5T619, Q66H04, Q6NRM8, Q6NV66, Q6ZSB9, Q7M6U3, Q7TS63, Q7TSH3, Q7ZWZ4, Q801P1, Q86VK4, Q8BKX7, Q8BXX2, Q8NAM6, Q8NAP3, Q8NCP5, Q8R0A2, Q91VW9, Q96IT1, Q96N77

Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

115 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance96
Likely benign8
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

1647 predictions. Top by Δscore:

VariantEffectΔscore
4:4290351:GG:Gdonor_gain1.0000
4:4290352:GG:Gdonor_gain1.0000
4:4300035:G:GAdonor_gain1.0000
4:4300095:TAGG:Tdonor_loss1.0000
4:4300096:AGG:Adonor_loss1.0000
4:4300099:T:Gdonor_loss1.0000
4:4313039:A:AGacceptor_gain1.0000
4:4313039:A:Cacceptor_loss1.0000
4:4313039:AG:Aacceptor_gain1.0000
4:4313040:G:GGacceptor_gain1.0000
4:4313040:GG:Gacceptor_gain1.0000
4:4313040:GGC:Gacceptor_gain1.0000
4:4313040:GGCA:Gacceptor_gain1.0000
4:4313112:GAG:Gdonor_gain1.0000
4:4313112:GAGGT:Gdonor_loss1.0000
4:4313113:AGGTC:Adonor_loss1.0000
4:4313114:GG:Gdonor_loss1.0000
4:4313115:G:GAdonor_loss1.0000
4:4313116:T:Adonor_loss1.0000
4:4315725:C:Gdonor_gain1.0000
4:4290319:GA:Gdonor_gain0.9900
4:4290321:G:GGdonor_gain0.9900
4:4299924:TAG:Tacceptor_loss0.9900
4:4299925:A:AGacceptor_gain0.9900
4:4299925:A:Gacceptor_loss0.9900
4:4299926:G:GGacceptor_gain0.9900
4:4300098:G:GGdonor_gain0.9900
4:4300767:G:GTdonor_gain0.9900
4:4301986:CAG:Cacceptor_loss0.9900
4:4301987:A:ACacceptor_loss0.9900

AlphaMissense

5101 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:4306176:T:CF432L1.000
4:4306178:C:AF432L1.000
4:4306178:C:GF432L1.000
4:4313061:C:AH441Q1.000
4:4313061:C:GH441Q1.000
4:4315637:T:CF460L1.000
4:4315639:T:AF460L1.000
4:4315639:T:GF460L1.000
4:4315811:T:CF488L1.000
4:4315813:T:AF488L1.000
4:4315813:T:GF488L1.000
4:4315895:T:CF516L1.000
4:4315897:T:AF516L1.000
4:4315897:T:GF516L1.000
4:4320732:T:CF572L1.000
4:4320734:T:AF572L1.000
4:4320734:T:GF572L1.000
4:4303046:T:CF404L0.999
4:4303048:T:AF404L0.999
4:4303048:T:GF404L0.999
4:4303071:T:CL412P0.999
4:4303073:C:AH413N0.999
4:4303073:C:GH413D0.999
4:4303080:G:CR415P0.999
4:4303085:C:GH417D0.999
4:4303087:T:AH417Q0.999
4:4303087:T:GH417Q0.999
4:4306149:T:CF423L0.999
4:4306151:T:AF423L0.999
4:4306151:T:GF423L0.999

dbSNP variants (sampled 300 via entrez): RS1000133948 (4:4319132 A>G), RS1000159393 (4:4292113 C>G), RS1000223465 (4:4296894 G>A), RS1000312132 (4:4307904 C>G,T), RS1000466940 (4:4291941 C>T), RS1000497713 (4:4291134 G>T), RS1000502222 (4:4317945 A>G,T), RS1001085566 (4:4307358 G>C,T), RS1001111313 (4:4301041 G>A), RS1001142612 (4:4299803 G>T), RS1001368327 (4:4295912 A>G), RS1001391622 (4:4306120 T>A,C), RS1001444812 (4:4299576 G>A), RS1001552014 (4:4310877 A>G), RS1001613941 (4:4311287 A>G)

Disease associations

OMIM: gene MIM:616238 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST005174_9Coronary artery calcified atherosclerotic plaque score in type 2 diabetes3.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004723coronary artery calcification

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

17 total (human), top 17 by PubMed support.

ChemicalActions (top 5)PubMed papers
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
triphenyl phosphateaffects expression1
arseniteincreases reaction, affects binding1
CGP 52608affects binding, increases reaction1
abrineincreases expression1
Sunitinibincreases expression1
Amiodaroneincreases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Cadmiumincreases abundance, increases expression1
Caffeinedecreases phosphorylation1
Dronabinoldecreases expression1
Tobacco Smoke Pollutionincreases expression1
Valproic Acidincreases methylation1
Cyclosporineincreases expression1
Aflatoxin B1increases methylation1
Cadmium Chlorideincreases abundance, increases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_HD00HEK293 eGFP-ZBTB49Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.